Back to Results

Effects of Your Genetics on the Contraceptive Implant (Nexplanon®)

Primary Objective

The pharmacogenomics of contraception: genetic determinants of etonogestrel pharmacokinetics

Study category: Healthy Volunteers

Is this Study for You?

Let's Get Started!

Description

1 visit lasting 30 minutes. Visit includes a questionnaire and a blood draw.

Duration of Participation: 1 day

Details
Age

18 to 45 years

Eligibility

? Age: 18-45 ? Have a Nexplanon for 1-4 years

Type of Study

Other

Scope

Local

Compensation

25

Location

University of Colorado Hospital

Principal Investigator
Aaron Lazorwitz,  MD, MSCS

Aaron Lazorwitz, MD, MSCS

Resources

Study ID

Protocol Number: 16-2462

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers